The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

A phase 1b/2 trial in triple-negative breast cancer will assess LP-184 alone and with a PARP inhibitor in advanced cases.

On this World Ovarian Cancer Day learn about the latest advances in treatment and research From genetic testing to CAR T-cell ...

Hone Health explains how inflammation-causing foods can wreak havoc on your body, and provides suggestions on what to eat ...

The inflammatory breast cancer market is poised for significant growth with a promising pipeline of emerging therapies targeting this rare but aggressive disease. Key breast cancer companies, ...

LTRN A May 5th press release indicated that the FDA cleared Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-184 trial in triple ...

Failure of a gene-reading quality-control mechanism called Integrator leaves cells littered with abnormal RNA strands that ...

Confident the three pillars of EFSA are working, Url believes the agency is ready for further transformation, specifically in ...

WASHINGTON (AP) — The Supreme Court on Tuesday allowed President Donald Trump’s administration to enforce a ban on ...

I am the shark among the fishes and the Ganges among the rivers says Krishna in Bhagavad Gita Ganga is India s most sacred river The last three Vedas Yajur Sama Atharva gave much importance to Ganga h ...

Commuters who travel between Delhi and Noida will now have to be more alert as the Noida Authority has carried out traffic ...